This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Assmann, G. Articles by Gotto, A. M. Search for Related Content PubMed PubMed Citation Articles by Assmann, G. Articles by Gotto, A. M., Jr Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL

(Circulation. 2004;109:III-8 – III-14.)
© 2004 American Heart Association, Inc.

Atherosclerosis: Evolving Vascular Biology and Clinical Implications

HDL Cholesterol and Protective Factors in Atherosclerosis

Gerd Assmann, MD; Antonio M. Gotto, Jr, MD, DPhil

From the Institute of Clinical Chemistry and Laboratory Medicine (G.A.), Central Laboratory, Westphalian Wilhelms-University, and the Institute of Arteriosclerosis Research at the University of Münster (G.A.), Münster, Germany; and Weill Medical College of Cornell University (A.M.G.), New York, NY.

Correspondence to Prof. Dr Gerd Assmann, Institute of Arteriosclerosis Research, University of Münster, Domagkstrasse 3, D-48149 Münster, Germany. E-mail assmann{at}uni-muenster.de

A low level of high-density lipoprotein cholesterol (HDL-C) is an important risk factor for cardiovascular disease. Epidemiological and clinical studies provide evidence that HDL-C levels are linked to rates of coronary events. The cardioprotective effects of HDL-C have been attributed to its role in reverse cholesterol transport, its effects on endothelial cells, and its antioxidant activity. Although some clinical trials suggest a benefit of raising HDL-C to reduce risk, further studies are needed, and HDL-C is still not considered a primary target of therapy in the National Cholesterol Education Program guidelines. However, HDL-C should be considered as part of the patient’s overall profile of established risk factors in determining treatment strategies.

Key Words: atherosclerosis • cardiovascular diseases • cholesterol • high-density lipoprotein (HDL) • lipoproteins • risk factors

This article has been cited by other articles:

				V. Y. Fujimoto, J. P. Kane, B. Y. Ishida, M. S. Bloom, and R. W. Browne High-density lipoprotein metabolism and the human embryo Hum. Reprod. Update, January 1, 2010; 16(1): 20 - 38. [Abstract] [Full Text] [PDF]